ABIVAX |
Market Closed -
Other stock markets
|
After market 02:32:53 pm | |||
| 7.140 EUR | -4.03% |
|
7.140 | 0.00% |
| Dec. 04 | JMP Securities Initiates Abivax at Market Outperform With $33 Price Target | MT |
| Nov. 14 | Abivax: appointment of board observer | CF |
Chart calendar Abivax
5599058f12.6c74luQwLl7YplmNNOOBOoTnT7JZem5b5Dly28PEwic.h7aL0oZieSS97xH1Z5vbftKKDdwTMFcOoQ8giKiUh3iFmI7RqQVUb7H-Lg~e00ef23f3ef2d92915a0d2fcc750f394
Upcoming events on Abivax
Past events on Abivax
| 2024-11-07 04:00 pm | Q3 2024 Earnings Release |
| 2024-10-15 08:30 am | United European Gastroenterology Week Meeting - Corticosteroid-free efficacy and safety of UC patien |
| 2024-10-15 08:30 am | United European Gastroenterology Week Meeting - Impact of obefazimod induction therapy |
| 2024-10-15 05:30 am | United European Gastroenterology Week Meeting |
| 2024-09-09 04:01 pm | Q2 2024 Earnings Release |
| 2024-05-30 04:00 am | Annual General Meeting |
| 2024-05-17 | Digestive Disease Week Conference - Booth #529 |
| 2024-04-08 08:30 am | Q4 2023 Earnings Call |
| 2024-04-02 02:30 am | Q4 2023 Earnings Release |
| 2024-02-23 12:22 pm | European Crohn And Colitis Organisation Conference - Oral Presentation (DOP)-71 |
| 2024-02-23 06:40 am | European Crohn And Colitis Organisation Conference - Poster Presentaition-985 |
| 2024-02-23 06:40 am | European Crohn And Colitis Organisation Conference - Poster Presentation-025 |
| 2024-02-23 01:15 am | ECCO Congress |
| 2024-02-22 11:57 am | European Crohn And Colitis Organisation Conference - Oral Presentation (DOP)-12 |
| 2024-02-06 02:00 pm | Investor Meeting - Key Opinion Leaders |
| 2024-01-24 | Crohn’s & Colitis Congress |
| 2023-11-29 03:30 pm | Piper Sandler Healthcare Conference |
| 2023-10-19 | ACG Meeting |
| 2023-10-16 05:30 am | United European Gastroenterology Meeting - OP077 |
| 2023-10-15 09:30 am | United European Gastroenterology Week - Abstract Number : MP085 |
Annual results
| Fiscal Period | December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
|
Net sales Million EUR | Released Forecast Spread | 9,70 33,7 -71.2% | 0,10 1,65 -93.94% | 4,60 2,62 75.6% | 7,93 | 5,65 | 5,71 |
|
EBITDA Million EUR | Released Forecast Spread | -42,4 -47,3 10.35% | -56,6 -55,2 -2.49% | -127 -98,8 -28.23% | -127 | -179 | -207 |
|
EBIT Million EUR | Released Forecast Spread | -42,6 -47,7 10.63% | -56,6 -55,5 -1.98% | -127 -99,5 -28.03% | -158 | -190 | -212 |
|
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | -45,6 -51,5 11.4% | -74,3 189 -139.32% | -148 -107 -37.8% | -182 | -199 | -238 |
|
Net income Million EUR | Released Forecast Spread | -41,4 -20,8 -99.18% | -69,8 -63,6 -9.83% | -147 -102 -44.64% | -167 | -195 | -218 |
|
EPS EUR | Released Forecast Spread | -2,47 -2,87 13.84% | -3,13 -0,87 -259.77% | -3,43 -1,93 -77.72% | -2,79 | -2,98 | -0,41 |
| Announcement Date | 16/03/22 | 19/04/23 | 02/04/24 | - |
Quarterly results
| Fiscal Period | June | 2023 S1 | 2023 S2 | 2024 Q1 | 2024 Q2 | 2024 S1 | 2024 Q3 | 2024 Q4 | 2024 S2 | 2025 Q1 | 2025 Q2 | 2025 S1 | 2025 Q3 | 2025 Q4 | 2025 S2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million EUR | Released Forecast Spread | 2,40 2,30 4.35% | 1,12 | 1,12 | 6,82 2,06 231.47% | 3,41 | 1,70 | 2,95 | 1,70 | 1,70 | 3,50 | 1,70 | 1,70 | 3,50 | |
|
EBIT Million EUR | Released Forecast Spread | -32,1 | -32,1 | -80,0 -89,0 10.13% | -40,0 | -43,9 | -92,8 | -44,7 | -45,4 | -88,6 | -46,1 | -46,9 | -91,3 | ||
|
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | -32,1 | -32,1 | -81,6 -96,7 15.58% | -40,8 | -44,3 | -103 | -44,7 | -45,4 | -46,1 | -46,9 | ||||
|
Net income Million EUR | Released Forecast Spread | -52,0 | -95,4 -45,0 -112% | -32,1 | -32,1 | -81,6 -93,1 12.34% | -40,8 | -44,3 | -96,7 | -44,7 | -45,4 | -88,6 | -46,1 | -46,9 | -91,3 |
|
EPS EUR | Released Forecast Spread | -1,45 | -1,30 -1,62 19.75% | -0,75 | -1,54 | -0,77 | -0,68 | -0,70 | -0,71 | ||||||
| Announcement Date | 29/09/23 | 02/04/24 | - | - | 09/09/24 | - | - | - | - | - | - | - | - | - |
More events
Past sector events for Abivax
| 2024-12-09 03:53 am | POLARIS GROUP: November 2024 Sales and Revenue Release |
| 2024-11-27 | FORMYCON AG: Q3 2024 Earnings Release |
| 2024-11-20 07:00 am | SEPTERNA, INC.: Q3 2024 Earnings Release |
| 2024-11-20 02:00 am | GENUS PLC: Q1 2025 Sales and Revenue Release - Trading Update |
| 2024-11-19 | MESOBLAST LIMITED: Q1 2025 Earnings Release (Projected) |
| 2024-11-14 08:00 am | ARRIVENT BIOPHARMA, INC.: Q3 2024 Earnings Release |
| 2024-11-14 08:00 am | SILENCE THERAPEUTICS PLC: Q3 2024 Earnings Release |
| 2024-11-14 02:00 am | BIOARCTIC AB: Q3 2024 Earnings Release |
| 2024-11-13 | VORONOI, INC.: Q3 2024 Earnings Release |
| 2024-11-13 | GNI GROUP LTD.: Q3 2024 Earnings Release |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- ABVX Stock
- Calendar Abivax